Related Experiment Video
Updated: Jul 19, 2026
08:20
Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
EFNS guidelines on management of narcolepsy
M Billiard1, C Bassetti, Y Dauvilliers
1School of Medicine, University of Montpellier, Montpellier, France. mbilliard@wanadoo.fr
European Journal of Neurology
|September 22, 2006
Summary
New guidelines for narcolepsy management emphasize modafinil for daytime sleepiness and sodium oxybate as a first-line treatment for cataplexy. Behavioral measures are also crucial for managing narcolepsy symptoms.
Area of Science:
- Neurology
- Pharmacology
Background:
- Narcolepsy management involves stimulants, antidepressants, and hypnotics, alongside behavioral strategies.
- Existing guidelines require updates due to evolving treatment landscapes, including increased modafinil use and the re-emergence of sodium oxybate.
Framework:
- A European task force reviewed pharmacological and behavioral trials for narcolepsy treatments.
- Evidence quality for various narcolepsy treatments varies, with a lack of comparative efficacy studies.
Implementation:
- Modafinil is the primary pharmacological treatment for excessive daytime sleepiness and sleep episodes, complemented by behavioral interventions.
- Sodium oxybate is now the first-line treatment for cataplexy, with antidepressants as second-line options.
Implications:
- Sodium oxybate's efficacy in treating multiple narcolepsy symptoms supports its growing use.
- Future treatment strategies will likely prioritize drugs evaluated in randomized controlled trials, potentially limiting the use of other compounds.
Related Concept Videos
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...